4//SEC Filing
Ebeling Thomas 4
Accession 0000950170-24-063948
CIK 0001789972other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:11 PM ET
Size
10.3 KB
Accession
0000950170-24-063948
Insider Transaction Report
Form 4
Ebeling Thomas
Director
Transactions
- Award
Common Stock
2024-05-23$12.73/sh+16,475$209,727→ 168,203 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-05-23−16,475→ 0 totalExercise: $12.73From: 2023-06-08Exp: 2032-06-21→ Common Stock (16,475 underlying) - Award
Common Stock
2024-05-23$4.30/sh+84,224$362,163→ 151,728 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-05-23−84,224→ 0 totalExercise: $4.30Exp: 2030-10-28→ Common Stock (84,224 underlying)
Footnotes (1)
- [F1]25% of the shares vested on August 16, 2018, and the remaining shares vested in 36 equal monthly installments thereafter.
Documents
Issuer
Cullinan Therapeutics, Inc.
CIK 0001789972
Entity typeother
Related Parties
1- filerCIK 0001297759
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 4:11 PM ET
- Size
- 10.3 KB